What are the treatment options for early-stage, low risk Hodgkin lymphoma (Hodgkin disease)?

Updated: Sep 12, 2018
  • Author: Bradley W Lash, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The treatment of these patients requires an individualized approach that provides enough therapy to eradicate the disease and avoid the long-term toxicity of treatment. Despite the existence of guidelines for the treatment, there must be room for individualized treatment, based on weighing of the benefits of therapy versus long-term toxicity.

In general, early-stage favorable Hodgkin lymphoma is treated with combined chemotherapy and radiation; however, there may be a role for chemotherapy alone. Randomized trials have shown that compared with radiation alone, combination chemotherapy followed by radiation is superior in terms of survival. [67]

The most commonly used regimen is ABVD (Adriamycin [doxorubicin], bleomycin, vinblastine, dacarbazine) for 2-4 cycles followed by involved-site radiation therapy (ISRT) (usually to 30 Gy). This regimen is the default regimen in the United States.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!